Replies to post #436277 on Anavex Life Sciences Corp (AVXL)

[georgejjl]

I understand your frustration. BUT he has repeatedly said that his goal is to maximize shareholder value in the long term. Wait until the Rett syndrome results are announced and the peer reviewed Phase 2b/3 results are released from the Alzheimer's trial.

Then wait for the FDA approval for Rett syndrome and accelerated approval for Alzheimer's disease treatment with blarcamesine, then we'll see if your grades for Dr. Christopher U. Missling MS PhD MBA go up.

Remember there are patients who have been waiting for years to get FDA approval for blarcamesine. We shareholders need patience to wait for FDA approval for blarcamesine.

Good luck and GOD bless,